Reflects the Intervention (AI Chatbot) (NCT06943911) | Clinical Trial Compass
Not Yet RecruitingNot Applicable
Reflects the Intervention (AI Chatbot)
Egypt122 participantsStarted 2025-04-20
Plain-language summary
The goal of this clinical trial is to investigate the impact of an AI-powered chatbot intervention on improving knowledge, attitudes, and empowerment in breast cancer patients. The study focuses on female breast cancer patients, aged 18 years or older, who are receiving treatment at Kafr El-Sheikh University Hospital in Egypt.
The main questions it aims to answer are:
Can the AI chatbot intervention improve breast cancer knowledge compared to standard care?
Can the AI chatbot intervention positively influence attitudes toward AI in healthcare?
Does the AI chatbot intervention enhance patient empowerment in managing breast cancer?
Researchers will compare:
Intervention group (AI chatbot + standard care) to control group (standard care alone) to see if the AI chatbot intervention leads to greater improvements in knowledge, more positive attitudes towards AI, and higher perceived empowerment.
Participants will:
Engage with an AI-powered chatbot designed to provide personalized education on breast cancer, treatment options, and emotional support.
Complete pre- and post-intervention assessments to measure changes in knowledge, attitudes toward AI, and empowerment.
Receive standard care, including routine oncology consultations and nursing support, alongside the chatbot intervention (for the intervention group).
Who can participate
Age range
18 Years
Sex
FEMALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
Female participants diagnosed with breast cancer, regardless of cancer stage.
Age 18 years or older.
Ability to read and communicate in Arabic to interact with the AI chatbot.
Willingness to participate in the study and to engage with the AI chatbot for the duration of the intervention.
Ability to provide informed consent.
Exclusion Criteria:
Participants with cognitive impairments or serious mental health conditions that may hinder understanding or participation in the study.
Patients currently receiving palliative care, as they may prioritize symptom management over educational interventions.
Participants who are physically unable to engage with the study's digital tools or complete assessments (e.g., due to severe illness).
Individuals who are unable to communicate in Arabic, as the AI chatbot intervention is designed in Arabic.
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.